Dr Reddy’s launches cancer drug biosimilar in India, targets 12 indications
Dr Reddy’s Laboratories has launched NIVORZ, a biosimilar to nivolumab, in India, marking the drugmaker’s entry into biosimilar immuno-oncology in the country.The company said on Tuesday that NIVORZ was developed and manufactured at its biologics facility in Bachupally, Hyderabad. The drug has been…